Navigation Links
Bioscience Company Chooses Microsoft Dynamics AX to Improve Support for Compliance With Industry Rules
Date:3/25/2008

PURE Bioscience picks Microsoft technology over competitors for its ease of

use, scalability and manufacturing capabilities.

REDMOND, Wash., March 25 /PRNewswire-FirstCall/ -- Microsoft Corp. today announced that PURE Bioscience has selected Microsoft Dynamics AX 4.0 to speed and integrate its business processes, helping to support the company's compliance with the Sarbanes-Oxley Act and with the requirements of numerous regulatory authorities, including the Food and Drug Administration (FDA) and Environmental Protection Agency (EPA) in the United States. Microsoft Dynamics AX is a comprehensive business-management solution for midsize and larger organizations that offers a high degree of scalability, customizability and full industry-specific functionality. It helps optimize and centralize supply chain processes and improves real-time visibility into operations.

(Logo: http://www.newscom.com/cgi-bin/prnh/20000822/MSFTLOGO)

PURE Bioscience, headquartered in El Cajon, Calif., develops and markets technology-based bioscience products that provide nontoxic solutions to numerous global health challenges. As a public company, PURE needed to remain compliant with Section 404 of the Sarbanes-Oxley Act. It also sought a way to produce its financials more rapidly because its growth would move the company into the category of an accelerated Securities and Exchange Commission (SEC) filer during 2008.

PURE had been relying significantly on legacy systems and spreadsheets for financial operations, but management saw a need to both integrate its data and find advanced technology for automating its processes to help manage the significant growth and increased complexity that the company anticipated.

The company evaluated a number of enterprise resource planning solutions to support its manufacturing and financial requirements, including FourthShif
'/>"/>

SOURCE Microsoft Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
2. Selection of Development Candidate Triggers $0.5 Million Milestone Payment to Ardea Biosciences, Inc.
3. ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook
4. Ohio Ranks Best in the Midwest for Venture Capital Investment in Health Care Bioscience Industry
5. ONCOSCIENCE AG, THE EUROPEAN PARTNER OF YM BIOSCIENCES, ANNOUNCES COMPLETION OF PATIENT ENROLLMENT IN PHASE III BRAIN CANCER TRIAL OF NIMOTUZUMAB
6. Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update
7. YM BIOSCIENCES, EUROPEAN PARTNER, ONCOSCIENCE AG, ANNOUNCES INITIATION OF ADVANCED NIMOTUZUMAB TRIALS IN ADULT GLIOMA AND PANCREATIC CANCER
8. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2007
9. Todd R. Nelson Named Chief Executive Officer of eBioscience, Inc.
10. Magellan Biosciences Names Steven E. Diamond, PhD, Chief Scientific Officer
11. Pressure BioSciences, Inc. Issued First Patent in Canada
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... New York, NY (PRWEB) May 22, 2013 ... My Cleaning Products said that there is a way to ... victims, it included on its latest post the details of ... spending too much money. , Mold could be prevented, My ... preventive measures, the company stated that a mold remediation must ...
(Date:5/22/2013)... A recent study from researchers in ... find that those who took probiotics were able to run ... study showed that in extreme heat conditions, probiotics were able ... acne treatment explains what this new discovery means ... their skin condition. , While researchers tote the benefits ...
(Date:5/21/2013)... Fla. , May 21, 2013  On ... FCN ), the global business advisory firm ... enterprise value (the "Company"), announced that it has ... that were formerly included within the Corporate Finance/Restructuring ... Consulting segment to form a single integrated practice ...
(Date:5/21/2013)... The results of a new study led by ... computational evidence that nucleation of ice in small ... understanding water,s behavior at the nanoscale. The formation ... basic scientific research question whose answer also has ... , The crystallization of ice from supercooled ...
Breaking Biology Technology:How to Kill Mold While Saving Thousands of Dollars on Mold Remediation Projects Explained by My Cleaning Products 2Adult Acne Treatment, Probiotic Action Shares Insight on New Findings Between Probiotics and Heat Tolerance, and What It Means for Acne Sufferers 2FTI Consulting Releases Realigned Segment Information Reflecting Newly Combined Health Solutions Practice 2Study led by GW professor provides better understanding of water's freezing behavior at nanoscale 2
... PITTSBURGH, March 30 Mylan Inc. (Nasdaq: ... India-based subsidiary in which it holds a 71.2% controlling ... U.S. Food and Drug Administration (FDA) under the President,s ... New Drug Application (ANDA) for Emtricitabine and Tenofovir Disoproxil ...
... Inverness Medical Innovations, Inc. (NYSE: IMA ), a ... health at home through the merger of rapid diagnostics and ... on its Series B Convertible Perpetual Preferred Stock (NYSE: IMA-PB). ... stock in an amount per share equal to the quotient ...
... Inc. (Nasdaq: GSIG ), a supplier of precision ... errors related to timing of the recognition of revenue from ... fiscal year 2006. The Audit Committee of the Board of ... potential adjustments resulting from the identified errors is material to ...
Cached Biology Technology:Mylan's Matrix Receives First Tentative FDA Approval Under PEPFAR for Generic Truvada(R) 2GSI Group Inc. to Restate Financial Results for 2006 2
(Date:5/20/2013)... the antibiotic colistin are also commonly resistant to ... to a study in mBio , the ... Microbiology. Cross-resistance to colistin and host antimicrobials LL-37 ... bacterial attack, could mean that patients with life-threatening ... crippled immune response. Colistin is a last-line drug ...
(Date:5/20/2013)... effect of physical education (PE) on child weight, but ... the amount of time that elementary schoolchildren spent in ... study represents some of the first evidence of a ... forthcoming in the Journal of Health Economics . ... be viewed at: http://www.sciencedirect.com/science/article/pii/S0167629613000556 , The research ...
(Date:5/20/2013)... COLUMBUS, Ohio New research suggests that a compound ... "superpower" to escape death. , By altering a ... re-educates cancer cells into normal cells that die as ... by inhibiting a process that would cause them to ... strict programming. This study in cells, led by Ohio ...
Breaking Biology News(10 mins):Resistance to last-line antibiotic makes bacteria resistant to immune system 2Resistance to last-line antibiotic makes bacteria resistant to immune system 3Gym class reduces probability of obesity, study finds for first time 2The compound in the Mediterranean diet that makes cancer cells 'mortal' 2The compound in the Mediterranean diet that makes cancer cells 'mortal' 3
... of Medicine (BCM) in Houston have reason to believe ... or control HIV infection, according to a study published ... , The study in mice boosted the immune response ... the immune system's full potential in conjunction with conventional ...
... of evolutionary detective work. Biology researchers at Lewis & ... evidence for an ancient transfer of a toxin between ... But the mystery remains as how the toxin passed ... month in the journal Bioinformatics, 22(3): 264-268, in an ...
... Weizmann Institute of Science recently discovered a new source ... were published in the Proceedings of the National Academy ... source of information on the evolution, population dynamics, migrations, ... it is not well preserved or becomes contaminated by ...
Cached Biology News:HIV vaccine takes different tack to boosting immune response 2Evolution mystery: Spider venom and bacteria share same toxin 2Ancient fossil DNA found preserved in crystal 2